AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficiency diploid rabies vaccine has successfully ...

The UK has announced new clinical trial regulatory reforms to boost its appeal as a leading destination for medical research.

The clinical trial ecosystem is entering a phase of consolidation and reinvention driven by the collapse of boundaries between functions, data, and even companies themselves.

We have a hit a new era of clinical trial design. Up until 2024, we’ve been doing this manually by taking a protocol that ...

Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...

World-leading challenge study expertise helping deliver scalable, high-quality outpatient vaccine trials in healthy ...

We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...

One of the major promises of artificial intelligence (AI) is its role in speeding up drug discovery. AI can process massive ...

Registrational myositis trial actively enrolling with planned 17-patient cohort and 2027 rese-cel BLA submission - including an outpatient dosing option using a single weight-based dose IND amendment ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Aligos Therapeutics, Inc. ("Aligos”, Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient ...

CK0804, a regulatory T cell therapy, received FDA orphan drug designation for myelofibrosis, supporting rare disease treatment development. Clinical study results showed significant reductions in ...